Month: February 2018
-
Embracing Technology for Better Business Efficiency
Finding technology that works to make your office more efficient in all aspects, from trading to productivity to saving money is essential towards achieving further growth in your company.
-
Scenes from the AAAS Annual Meeting
There’s more going on at the AAAS meeting than papers and presentations, including Family Science Days, always a big hit with kids of all ages.
-
Gut Tissue From Stem Cells Simulated on Organ Chips
Researchers created working human gut tissue cells derived from stem cells, grown on plastic chips simulating intestinal diseases, as a tool for testing effectiveness and safety of treatments before given to patients.
-
Alexa, How Will Amazon Echo Affect My Business?
What on earth is the IoT, you ask? Well, it’s a digital presence connecting everyday household items and the internet.
-
NIH Exec: Research Offers Opioid Crisis Solutions
The director of the National Institute on Drug Abuse says recent research in neuroscience and pharmacology reveals possible pathways out of the current epidemic of opioid addiction and overdose deaths.
-
Cancer Analytics Company Acquired in $1.9B Deal
The global pharmaceutical company Roche is purchasing the cancer data management and analytics enterprise Flatiron Health in New York for $1.9 billion.
-
Going to Austin, City with No Limits
Science & Enterprise is headed to Austin, Texas to cover the annual meeting of American Association for the Advancement of Science, or AAAS, and we will report from the meeting from Friday through Sunday.
-
FDA Clears First Blood Test for Concussions
The Food and Drug Administration authorized for marketing in the U.S. a blood test that screens for chemical indicators in the blood for concussions, a form of traumatic brain injury.
-
Lab Burns Graphene Circuits into Food, Fabrics
A chemistry lab at Rice University devised a process for producing graphene, a material that conducts electricity, in materials containing carbon, including fabrics and even food.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.